Journal
NUTRITIONAL NEUROSCIENCE
Volume 22, Issue 11, Pages 750-759Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/1028415X.2018.1436639
Keywords
Alzheimer disease; Dementia; Meta-analysis; Vitamin D deficiency
Categories
Ask authors/readers for more resources
Objective: We aimed to test the dose-response association of serum 25(OH)D and risk of dementia and Alzheimer's disease (AD). Methods: We performed a systematic search of PubMed and Scopus from database inception up to September 2017. Longitudinal cohort studies reporting risk estimates of incident dementia or AD in the general population, and for three or more quantitative categories of serum 25(OH)D were included. Pooled hazard ratios (HRs) were calculated using fixed-effects/random-effects models. Results: Seven prospective cohort studies and one retrospective cohort study (total n = 28,354) involving 1953 cases of dementia and 1607 cases of AD were included. The pooled HRs of dementia and AD were 1.09 (95%CI: 0.95, 1.24) and 1.19 (95%CI: 0.96, 1.41) for vitamin D insufficiency (10-20 ng/ml), and 1.33 (95%CI: 1.08, 1.58) and 1.31 (95%CI: 0.98, 1.65) for deficiency (<10 ng/ml), respectively. The lower risk of dementia was observed at serum 25(OH)D of similar to 25 ng/ml, whereas the risk of AD decreased continuously along with the increase of serum 25(OH)D up to similar to 35 ng/ml. Conclusion: Higher levels of serum 25(OH)D was associated with a lower risk of dementia and AD, but we have no conclusive evidence regarding serum 25(OH)D levels of >35 ng/ml.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available